Trial Profile
A Phase 1/2 Study of E6005 in Japanese Patients With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Lotamilast (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eisai Co Ltd
- 11 Jun 2014 New trial record